CertaraCERT +1.20%59 FCF Yield % is 7.42 as of Jun. 24, 2026, which is 198% above its 10-year median of 2.49. GuruFocus rates CERT with a GF Score™ of 59/100 and a GF Value™ of $13.40 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Certara ranks better than 74.49% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Certara's Trailing 12-Month Free Cash Flow is $63.1 Mil, and Market Cap is $850.2 Mil. Therefore, Certara's FCF Yield % for today is 7.42%.
The historical rank and industry rank for Certara's FCF Yield % or its related term are showing as below:
CERT'
s FCF Yield % Range Over the Past 10 Years
Min: 0.62 Med: 2.49 Max: 8.93
Current: 7.42
During the past 8 years, the highest FCF Yield % of Certara was 8.93%. The lowest was 0.62%. And the median was 2.49%.
CERT's FCF Yield % is ranked better than 74.49% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.875
vs CERT: 7.42
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Certara FCF Yield % Related Terms
Certara FCF Yield % Historical Data
* Premium members only.
The historical data trend for Certara's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Certara's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Certara FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Certara's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Certara's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara (CERT) has a FCF Yield % of 7.42 as of Jun. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Certara and its competitors. This is 198% above median its historical median of 2.49. Over the past decade, Certara's FCF Yield % has ranged from 0.62 to 8.93. According to the industry distribution chart, Certara ranks #175 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 25.5%.
Is Certara's FCF Yield % too high?
Certara's current FCF Yield % of 7.42 is 198% above median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 8.93. The Healthcare Providers & Services industry median FCF Yield % is 1.88. Certara's value of 7.42 is 295.7% above this industry median. Based on the distribution chart, Certara ranks #175 out of 686 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Certara has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Certara's FCF Yield % compare to TALK and GDRX?
According to the Healthcare Providers & Services industry distribution chart, Certara ranks #175 out of 686 companies for FCF Yield %. This puts Certara in the upper half of its industry. The industry median FCF Yield % is 1.88. Certara's value of 7.42 is 295.7% above this benchmark. Historically, Certara's own FCF Yield % has ranged from 0.62 to 8.93 over the past decade. While the company's 10-year median is 2.49 vs. the industry median of 1.88, Certara has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Certara's current FCF Yield % of 7.42 is 295.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Certara and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Certara's current FCF Yield % is 7.42, which is 198% above median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Possible Value Trap. The stock's GF Value™ is $13.40, compared to a current price of $5.47 — trading 59.2% below its estimated fair value. The current FCF Yield % is 7.42, which is 198% above median its 10-year median of 2.49 and 295.7% above the Healthcare Providers & Services industry median of 1.88. Certara's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Certara (CERT), the current FCF Yield % is 7.42 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Certara (CERT) Overvalued in 2026?
Based on GuruFocus' analysis, Certara stock appears to be undervalued.
The current stock price of $5.47 is trading 59.2% below its estimated GF Value™ of $13.40.
GuruFocus considers Certara to be Possible Value Trap.
Key valuation signals for CERT:
FCF Yield %: 7.42 (198% above median its 10-year median of 2.49)
GF Value™: $13.40 vs. price of $5.47 (59.2% below fair value)
Industry Position: 295.7% above the Healthcare Providers & Services median (#175 of 686)
No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
59GF Score
Get the complete analysis for CERT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CERT has been successfully added to your 
